Topic
DETROIT (June 9, 2023) – TRUSANOTM, a state-of-the-art data and document anonymization, redaction, and masking software, is now available globally. Developed by TrialAssure – an award-winning leader in…
EMA Policy 0070 will be relaunched effective September 2023, as announced by the European Medicines Agency (EMA) during a webinar on Tuesday, May 16, 2023. Now, all Marketing…
Quantitative Risk Analysis (QRA) is a systematic approach that enables researchers to identify, evaluate, and manage risks within the clinical trial process, and clinical trials are a pivotal…
Company Confidential Information (CCI) and the need to understand what it is and what it is not, is a hotly-debated topic in the pharmaceutical industry, especially in 2023.…
TrialAssure ANONYMIZE® enables rapid, accurate data and document anonymization and redaction, and one common question that we receive from users is “how do I customize replacement text?” To…
TrialAssure ANONYMIZE® is the data, document, and image anonymization and redaction technology that empowers you to share information with confidence, knowing that patient and company confidentiality are protected.…
TrialAssure ANONYMIZE® employs powerful machine learning to enable you to redact or anonymize unstructured clinical documents, structured datasets, and medical images. And, one of the common questions that…
CANTON, Mich. and OTTAWA (October 18, 2022) – TrialAssure, a leading, global software-as-a- service (SaaS) provider advancing clinical trial disclosure, data sharing, and transparency, announced today that it…
News We had an exciting year, including partnering with Certara, winning Data Solution of the Year, and releasing TrialAssure LINK. Here’s a look back at 2021. Certara Adopts TrialAssure ANONYMIZE Solution…
“Originally published on TrialSite News on June 28, 2021” Clinical trial transparency is quickly emerging as a critical function within sponsor and academic organizations, as its importance in the pharmaceutical, biotechnology, and medical…
